Holen Sie sich die Stockscreener-App
123.41
1.06%
-1.32
Handel nachbörslich:
123.41
Schlusskurs vom Vortag:
$124.73
Offen:
$125.1
24-Stunden-Volumen:
997.31K
Relative Volume:
1.43
Marktkapitalisierung:
$7.00B
Einnahmen:
$602.35M
Nettoeinkommen (Verlust:
$-1.90M
KGV:
60.79
EPS:
2.03
Netto-Cashflow:
$119.26M
1W Leistung:
-11.54%
1M Leistung:
-16.02%
6M Leistung:
-28.22%
1J Leistung:
-18.05%
1-Tages-Spanne:
$122.02
$126.25
1-Wochen-Bereich:
$121.52
$154.48
52-Wochen-Spanne:
$113.50
$211.13
Repligen Corp Stock (RGEN) Company Profile
Firmenname
Repligen Corp
Sektor
Telefon
(781) 449-9560
Adresse
41 SEYON STREET, WALTHAM, MA
Vergleichen Sie RGEN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| RGEN | 123.41 | 7.00B | 602.35M | -1.90M | 119.26M | 2.03 |
| ISRG | 531.64 | 190.09B | 7.87B | 2.24B | 586.00M | 4.25 |
| BDX | 224.10 | 65.14B | 20.18B | 1.73B | 3.07B | 5.51 |
| ALC | 85.81 | 42.44B | 9.76B | 1.16B | 665.00M | 0.72 |
| RMD | 239.42 | 34.99B | 4.81B | 1.11B | 1.35B | 6.16 |
| WST | 307.21 | 22.29B | 2.88B | 499.60M | 321.60M | 7.41 |
Repligen Corp Stock (RGEN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-26 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-06-18 | Eingeleitet | Guggenheim | Neutral |
| 2023-12-04 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2023-07-20 | Eingeleitet | Wells Fargo | Overweight |
| 2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
| 2023-03-28 | Eingeleitet | The Benchmark Company | Buy |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Hold |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2022-07-20 | Eingeleitet | UBS | Buy |
| 2021-10-14 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-08-24 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-30 | Bestätigt | H.C. Wainwright | Buy |
| 2020-05-07 | Bestätigt | H.C. Wainwright | Buy |
| 2020-03-23 | Bestätigt | H.C. Wainwright | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Buy |
| 2019-11-01 | Hochstufung | First Analysis Sec | Outperform → Strong Buy |
| 2019-10-15 | Eingeleitet | SVB Leerink | Outperform |
| 2019-08-28 | Bestätigt | First Analysis Sec | Outperform |
| 2019-08-23 | Fortgesetzt | Stephens | Overweight |
| 2019-07-22 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2018-12-17 | Hochstufung | CL King | Neutral → Buy |
| 2018-11-12 | Herabstufung | CL King | Buy → Neutral |
| 2018-09-26 | Eingeleitet | H.C. Wainwright | Neutral |
| 2017-12-08 | Eingeleitet | Citigroup | Buy |
| 2017-12-05 | Eingeleitet | JP Morgan | Overweight |
| 2017-11-13 | Eingeleitet | CL King | Buy |
| 2017-10-02 | Hochstufung | First Analysis Sec | Equal-Weight → Overweight |
| 2017-07-21 | Eingeleitet | William Blair | Outperform |
| 2017-02-13 | Hochstufung | Piper Jaffray | Neutral → Overweight |
Alle ansehen
Repligen Corp Aktie (RGEN) Neueste Nachrichten
Repligen Co. (NASDAQ:RGEN) Shares Purchased by Thrivent Financial for Lutherans - MarketBeat
Wolfe Research Initiates Coverage on Repligen (NASDAQ:RGEN) - Defense World
Analysts Issue Forecasts for Repligen FY2024 Earnings - MarketBeat
Aigen Investment Management LP Has $487,000 Stake in Repligen Co. (NASDAQ:RGEN) - MarketBeat
Repligen Co. (NASDAQ:RGEN) Shares Sold by Principal Financial Group Inc. - MarketBeat
StockNews.com Upgrades Repligen (NASDAQ:RGEN) to “Hold” - Defense World
Wolfe Research initiates Repligen shares coverage with Peerperform rating - Investing.com
Sivik Global Healthcare LLC Has $3.72 Million Stock Holdings in Repligen Co. (NASDAQ:RGEN) - MarketBeat
Repligen (NASDAQ:RGEN) Issues Quarterly Earnings Results - MarketBeat
Repligen Corporation (NASDAQ:RGEN) Q3 2024 Earnings Call Transcript - Insider Monkey
Versor Investments LP Takes $893,000 Position in Repligen Co. (NASDAQ:RGEN) - MarketBeat
Company News for Nov 13, 2024 - Yahoo Finance
Repligen Corp (RGEN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
Repligen Corp (RGEN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
Repligen: Q3 Earnings Snapshot - Houston Chronicle
Repligen shares hold as KeyBanc maintains $220 target - Investing.com
Repligen Q3 Earnings Beat Expectations, Highlights Improving Market Conditions, Analyst Says Well-Positioned For Long-Term GrowthRepligen (NASDAQ:RGEN) - Benzinga
Repligen earnings beat by $0.10, revenue topped estimates - Investing.com
Repligen Stock Soars 10% on Record Growth and Bold Moves - Yahoo Finance
Repligen Corp Q3 2024 Earnings: Revenue Beats Estimates at $154. - GuruFocus.com
Repligen Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Repligen (RGEN) Q3 Earnings and Revenues Beat Estimates - Yahoo Finance
Repligen (NASDAQ:RGEN) Updates FY 2024 Earnings Guidance - MarketBeat
Repligen (NASDAQ:RGEN) Updates FY24 Earnings Guidance - MarketBeat
WCM Investment Management LLC Increases Stock Position in Repligen Co. (NASDAQ:RGEN) - MarketBeat
Repligen Corp (RGEN) Q3 2024: Everything You Need to Know Ahead of Earnings - GuruFocus.com
Repligen Co. (NASDAQ:RGEN) Shares Purchased by TimesSquare Capital Management LLC - MarketBeat
Van ECK Associates Corp Has $5.38 Million Stake in Repligen Co. (NASDAQ:RGEN) - MarketBeat
US Bancorp DE Cuts Stock Holdings in Repligen Co. (NASDAQ:RGEN) - MarketBeat
Repligen (RGEN) Set to Announce Earnings on Tuesday - MarketBeat
Repligen CEO to Present at Major UBS, Stifel, and Stephens Healthcare Conferences | RGEN Stock News - StockTitan
Impax Asset Management Group plc Lowers Position in Repligen Co. (NASDAQ:RGEN) - MarketBeat
Repligen Co. (NASDAQ:RGEN) Position Boosted by Blue Trust Inc. - Defense World
New York State Common Retirement Fund Acquires 71,274 Shares of Repligen Co. (NASDAQ:RGEN) - MarketBeat
Conestoga Capital Advisors LLC Sells 6,167 Shares of Repligen Co. (NASDAQ:RGEN) - MarketBeat
Repligen to Report Third Quarter 2024 Financial Results - StockTitan
Repligen Co. (NASDAQ:RGEN) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Repligen Co. (NASDAQ:RGEN) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World
Raymond James & Associates Increases Stock Holdings in Repligen Co. (NASDAQ:RGEN) - MarketBeat
Allspring Global Investments Holdings LLC Has $37.81 Million Stock Holdings in Repligen Co. (NASDAQ:RGEN) - MarketBeat
Repligen (NASDAQ:RGEN) Shares Gap DownHere's Why - MarketBeat
Repligen (RGEN) Earnings Expected to Grow: What to Know Ahead of Q3 Release - Yahoo Finance
Repligen (NASDAQ:RGEN) Shares Gap UpHere's Why - MarketBeat
Repligen Corp (RGEN) Trading 3.16% Higher on Oct 17 - GuruFocus.com
Repligen Corp. (RGEN) gets rating Initiated from Wells Fargo - Knox Daily
Global Hollow Fiber Filtration Market Overall Study Report - openPR
Peptide Therapeutics Industry Report 2024, Featuring Profiles of 30+ Leading Players Including PeptiDream, PolyPeptide, Repligen, X-GEN Pharmaceuticals, Zydus Cadila and More - Yahoo Finance
Diversified Trust Co Purchases 7,520 Shares of Repligen Co. (NASDAQ:RGEN) - MarketBeat
Financial Analysis: Repligen Corp. (RGEN)’s Ratios Unveil Key Insights - The Dwinnex
Taking the lead: Repligen Corp. (RGEN) - SETE News
Examining the Potential Price Growth of Repligen Corp. (RGEN) - Knox Daily
Finanzdaten der Repligen Corp-Aktie (RGEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.70%
3.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):